Question 1

Does BNP Paribas Financial Markets own CRDF stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BNP Paribas Financial Markets holds 228,461 shares of CRDF (Cardiff Oncology), worth $296,999.

Question 2

How many shares of CRDF does BNP Paribas Financial Markets own?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets holds 228,461 shares of CRDF (Cardiff Oncology).

Question 3

What is BNP Paribas Financial Markets' CRDF position worth?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets' CRDF position is worth $296,999.

Question 4

Is BNP Paribas Financial Markets buying or selling CRDF?

Accepted Answer

In Q2 2026, BNP Paribas Financial Markets increased its CRDF position from 13,076 to 228,461 shares.

Question 5

When did BNP Paribas Financial Markets first buy CRDF?

Accepted Answer

BNP Paribas Financial Markets first reported CRDF in its Q4 2024 13F and has listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	228,461	+1647.2%	$296,999	0.0%	$1.30	38
2026-Q1	Increased	13,076	+3.5%	$21,183	0.0%	$1.62	13
2025-Q4	Increased	12,640	+9.1%	$35,518	0.0%	$2.81	15
2025-Q3	Decreased	11,582	-25.0%	$23,859	0.0%	$2.06	0
2025-Q2	Increased	15,437	+335.1%	$48,627	0.0%	$3.15	22
2025-Q1	Decreased	3,548	-38.1%	$11,141	0.0%	$3.14	0
2024-Q4	New	5,733	-	$24,881	0.0%	$4.34	29

CRDF7 quarters

CRDF
7 quarters